BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8751561)

  • 41. Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
    Nishio S; Ota S; Sugiyama T; Matsuo G; Kawagoe H; Kumagai S; Ushijima K; Nishida T; Kamura T
    Int J Clin Oncol; 2003 Feb; 8(1):45-8. PubMed ID: 12601542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
    Homesley HD; Filiaci V; Markman M; Bitterman P; Eaton L; Kilgore LC; Monk BJ; Ueland FR;
    J Clin Oncol; 2007 Feb; 25(5):526-31. PubMed ID: 17290061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.
    Curtin JP; Blessing JA; Soper JT; DeGeest K
    Gynecol Oncol; 2001 Nov; 83(2):268-70. PubMed ID: 11606082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion].
    Noda K; Ikeda M; Kudo R; Nishiya I; Yajima A; Tanaka K; Kodama S; Takahashi T; Tokunaga A; Satoh I; Nozawa S; Taketani Y; Terashima Y; Isonishi S; Takeda Y; Nishijima M; Kuroshima Y; Fujii S; Izumi R; Tamaya T; Mori T; Okada H; Ogita S; Ozaki M; Hatae M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):317-25. PubMed ID: 8712825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
    Lincoln S; Blessing JA; Lee RB; Rocereto TF
    Gynecol Oncol; 2003 Mar; 88(3):277-81. PubMed ID: 12648575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinoma: a Southwest Oncology Group study.
    Whitehead RP; Jacobson J; Brown TD; Taylor SA; Weiss GR; Macdonald JS
    J Clin Oncol; 1997 Jun; 15(6):2414-9. PubMed ID: 9196157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; McGuire WP; Adcock L
    Cancer; 1994 Mar; 73(5):1453-5. PubMed ID: 8111713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidrug treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Cohen CJ; Bruckner HW; Deppe G; Blessing JA; Homesley H; Lee JH; Watring W
    Obstet Gynecol; 1984 May; 63(5):719-26. PubMed ID: 6371627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of weekly paclitaxel chemotherapy for esophageal cancer].
    Kawada J; Nishimura M; Matsui Y; Nomura M; Noguchi Y; Okumura Y; Danno K; Kubota M; Matsuda C; Omori K; Nishikawa K; Nomura M; Takagi M; Fukui A; Fujitani K; Iwase K; Tanaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2118-20. PubMed ID: 24394032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Thigpen JT; Buchsbaum HJ; Mangan C; Blessing JA
    Cancer Treat Rep; 1979 Jan; 63(1):21-7. PubMed ID: 369691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer.
    Lissoni A; Zanetta G; Losa G; Gabriele A; Parma G; Mangioni C
    Ann Oncol; 1996 Oct; 7(8):861-3. PubMed ID: 8922203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.
    Gallup DG; Blessing JA; Andersen W; Morgan MA;
    Gynecol Oncol; 2003 Apr; 89(1):48-51. PubMed ID: 12694653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.
    Burton ER; Brady M; Homesley HD; Rose PG; Nakamura T; Kesterson JP; Rotmensch J; Tate Thigpen J; Van Le L
    Gynecol Oncol; 2016 Jan; 140(1):48-52. PubMed ID: 26616224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
    Jones DV; Lozano R; Hoque A; Markowitz A; Patt YZ
    J Clin Oncol; 1996 Aug; 14(8):2306-10. PubMed ID: 8708721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group.
    Schilder RJ; Blessing JA; Pearl ML; Rose PG
    Invest New Drugs; 2004 Aug; 22(3):343-9. PubMed ID: 15122083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
    Kudelka AP; Winn R; Edwards CL; Downey G; Greenberg H; Dakhil SR; Freedman RS; LoCoco S; Umbreit J; Delmore JE; Arbuck S; Loyer E; Gacrama P; Fueger R; Kavanagh JJ
    Anticancer Drugs; 1997 Aug; 8(7):657-61. PubMed ID: 9311440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
    Garcia AA; Leichman CG; Lenz HJ; Baranda J; Lujan R; Casagrande Y; Leichman L
    Jpn J Clin Oncol; 2001 Jun; 31(6):275-8. PubMed ID: 11463806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II trial of paclitaxel (Taxol) as first line treatment in advanced breast cancer.
    Swain SM; Honig SF; Tefft MC; Walton L
    Invest New Drugs; 1995; 13(3):217-22. PubMed ID: 8729949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.